121 related articles for article (PubMed ID: 17124955)
1. [Biliary lithiasis and cholecystitis with voriconazole: about 3 cases].
Gérardin-Marais M; Allain-Veyrac G; Danner I; Jolliet P
Therapie; 2006; 61(4):367-9. PubMed ID: 17124955
[No Abstract] [Full Text] [Related]
2. High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
Rondeau S; Couderc L; Dominique S; Pramil S; Leguillon C; Masseline B; Favennec L; Marguet C
Eur Respir J; 2012 Mar; 39(3):782-4. PubMed ID: 22379155
[No Abstract] [Full Text] [Related]
3. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Ibrahim SF; Singer JP; Arron ST
Dermatol Surg; 2010 Nov; 36(11):1752-5. PubMed ID: 20533939
[No Abstract] [Full Text] [Related]
4. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
5. Safety of voriconazole and dose individualization.
Lutsar I; Hodges MR; Tomaszewski K; Troke PF; Wood ND
Clin Infect Dis; 2003 Apr; 36(8):1087-8. PubMed ID: 12684928
[No Abstract] [Full Text] [Related]
6. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
Wise SM; Wilson MA
Clin Nucl Med; 2011 Mar; 36(3):242-4. PubMed ID: 21285691
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
Cheng MP; Paquette K; Lands LC; Ovetchkine P; Théoret Y; Quach C
Pediatr Pulmonol; 2010 Jul; 45(7):661-6. PubMed ID: 20575095
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.
Luong ML; Hosseini-Moghaddam SM; Singer LG; Chaparro C; Azad S; Lazar N; Boutros PC; Keshavjee S; Rotstein C; Husain S
Am J Transplant; 2012 Jul; 12(7):1929-35. PubMed ID: 22486950
[TBL] [Abstract][Full Text] [Related]
10. Pseudoporphyria associated with voriconazole.
Kwong WT; Hsu S
J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
[TBL] [Abstract][Full Text] [Related]
11. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Tedja R; El-Sherief A; Olbrych T; Gordon S
Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
[TBL] [Abstract][Full Text] [Related]
12. [Voriconazole-associated phototoxicity].
Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
[No Abstract] [Full Text] [Related]
13. [Complex visual hallucinations induced by voriconazole].
Fernández-Ruiz M; López-Medrano F; Gutiérrez E; Aguado JM
Med Clin (Barc); 2009 Jun; 133(4):156-7. PubMed ID: 19540418
[No Abstract] [Full Text] [Related]
14. Adverse effects of voriconazole.
Lohr L
Orthopedics; 2004 May; 27(5):472-3. PubMed ID: 15181941
[No Abstract] [Full Text] [Related]
15. [Hallucinosis as side effect of voriconazole].
Flox Benítez G; Rondón Fernández P; Quero Escalada M; Fernández Ballesteros A
Rev Clin Esp; 2005 Dec; 205(12):632-3. PubMed ID: 16527191
[No Abstract] [Full Text] [Related]
16. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Ayub A; Kenney CV; McKiernan FE
J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
[TBL] [Abstract][Full Text] [Related]
17. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Wang TF; Wang T; Altman R; Eshaghian P; Lynch JP; Ross DJ; Belperio JA; Weigt SS; Saggar R; Gregson A; Kubak B; Saggar R
Am J Transplant; 2009 Dec; 9(12):2845-50. PubMed ID: 19845595
[TBL] [Abstract][Full Text] [Related]
18. [Voriconazole safety: short review of clinical data].
Veselov AV; Belousov DIu
Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
[No Abstract] [Full Text] [Related]
19. Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
Lustenberger DP; Granata JD; Scharschmidt TJ
Orthopedics; 2011 Nov; 34(11):e793-6. PubMed ID: 22049971
[TBL] [Abstract][Full Text] [Related]
20. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
